PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K105. A total of 55 filers reported holding PHOENIX BIOTECH ACQUISITION in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,754,152 | -65.3% | 170,970 | -65.9% | 0.09% | -47.1% |
Q3 2022 | $5,062,000 | +0.7% | 501,164 | 0.0% | 0.17% | +8.3% |
Q2 2022 | $5,027,000 | +100.9% | 501,164 | +100.3% | 0.16% | +127.5% |
Q1 2022 | $2,502,000 | +1.0% | 250,166 | +0.1% | 0.07% | +3.0% |
Q4 2021 | $2,478,000 | – | 250,000 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Yakira Capital Management, Inc. | 108,103 | $1,177,782 | 0.32% |
METEORA CAPITAL, LLC | 169,897 | $1,841,683 | 0.31% |
Mint Tower Capital Management B.V. | 141,089 | $1,532 | 0.24% |
BERKLEY W R CORP | 47,199 | $512,581 | 0.03% |
Shaolin Capital Management LLC | 50,000 | $543 | 0.02% |
CLEAR STREET LLC | 73,364 | $797 | 0.01% |
Walleye Capital LLC | 47,936 | $520,585 | 0.00% |
Walleye Trading LLC | 26,964 | $292,829 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 10,588 | $114,985 | 0.00% |